---
{"dg-publish":true,"permalink":"/entities/drug/memantine/","tags":["drug","nmda_antagonist","dementia","alzheimers","neuroprotective","prescription"]}
---


# Memantine

## Overview
NMDA receptor antagonist for moderate-severe Alzheimer's disease. Blocks excessive glutamate signaling that contributes to neurodegeneration. Often used with cholinesterase inhibitors.

**Short Description**: NMDA antagonist for moderate-severe Alzheimer's

## Pharmacological Information

**DrugBank ID**: DB01043

**Drug Class**: NMDA Receptor Antagonist

**Synonyms**:
- Namenda
- Ebixa

### Mechanism of Action
Uncompetitive NMDA receptor antagonism, reducing excitotoxicity

## Clinical Features

## Classification

## Chemical Properties
No content available.

## Relationships

### Interactswith
- → [[entities/drug/Imipramine\|Imipramine]] (drug)
```yaml
imported: '2025-12-26T11:56:37.022000+00:00'
source: PrimeKG
```
- → [[entities/drug/Quetiapine\|Quetiapine]] (drug)
```yaml
imported: '2025-12-26T11:56:37.681000+00:00'
source: PrimeKG
```

### Related
- ← [[entities/drug/Imipramine\|Imipramine]] (drug)
- → [[entities/drug/Quetiapine\|Quetiapine]] (drug)
- → [[entities/drug/Imipramine\|Imipramine]] (drug)
- ← [[entities/drug/Quetiapine\|Quetiapine]] (drug)
